158 related articles for article (PubMed ID: 12673715)
1. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis.
Zeegers MP; Jellema A; Ostrer H
Cancer; 2003 Apr; 97(8):1894-903. PubMed ID: 12673715
[TBL] [Abstract][Full Text] [Related]
2. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
Grönberg H; Wiklund F; Damber JE
Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
[TBL] [Abstract][Full Text] [Related]
3. Age at diagnosis and age at death in familial prostate cancer.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
[TBL] [Abstract][Full Text] [Related]
4. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
5. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
Hemminki K; Czene K
Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
[TBL] [Abstract][Full Text] [Related]
6. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
7. Higher frequency of familial clustering of prostate cancer in French-Canadian men.
Filion E; Taussky D; Bahary JP; Maugard CM
J Urol; 2007 Oct; 178(4 Pt 1):1265-9; discussion 1270. PubMed ID: 17698103
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
9. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer.
Schuurman AG; Zeegers MP; Goldbohm RA; van den Brandt PA
Epidemiology; 1999 Mar; 10(2):192-5. PubMed ID: 10069259
[TBL] [Abstract][Full Text] [Related]
10. Risk perception and concern among brothers of men with prostate carcinoma.
Beebe-Dimmer JL; Wood DP; Gruber SB; Chilson DM; Zuhlke KA; Claeys GB; Cooney KA
Cancer; 2004 Apr; 100(7):1537-44. PubMed ID: 15042690
[TBL] [Abstract][Full Text] [Related]
11. Familial risk factors for prostate cancer.
Carter BS; Steinberg GD; Beaty TH; Childs B; Walsh PC
Cancer Surv; 1991; 11():5-13. PubMed ID: 1841757
[TBL] [Abstract][Full Text] [Related]
12. Decreasing age at prostate cancer diagnosis over successive generations in prostate cancer families.
Bock CH; Peyser PA; Montie JE; Cooney KA
Prostate; 2005 Jun; 64(1):60-6. PubMed ID: 15651090
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
Canby-Hagino E; Hernandez J; Brand TC; Troyer DA; Higgins B; Ankerst DP; Thompson IM; Leach RJ; Parekh DJ
Urology; 2007 Oct; 70(4):748-52. PubMed ID: 17991549
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
15. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
Peters CA; Stock RG; Blacksburg SR; Stone NN
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
17. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database.
Kerber RA; O'Brien E
Cancer; 2005 May; 103(9):1906-15. PubMed ID: 15779016
[TBL] [Abstract][Full Text] [Related]
18. Cancer in first-degree relatives and risk of glioma in adults.
Hill DA; Inskip PD; Shapiro WR; Selker RG; Fine HA; Black PM; Linet MS
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1443-8. PubMed ID: 14693735
[TBL] [Abstract][Full Text] [Related]
19. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinoma among men with human immunodeficiency virus infection.
Crum NF; Spencer CR; Amling CL
Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]